Plain-English translation of NCT06207812 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is looking at long-term outcomes in young people diagnosed with two types of skin lymphomas: mycosis fungoides and lymphomatoid papulosis. Researchers at M.D. Anderson Cancer Center want to understand how these conditions progress over 5 to 10 years, what treatments work best, and how they affect quality of life.
These are rare skin lymphomas that occur in children and young adults, but there is limited information about their long-term outcomes and how they respond to different treatments. This study aims to fill that gap so doctors can better help young patients with these conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you (or your parent, if you're under 18) will be asked to share information about your diagnosis, treatments you've received, and how the condition has affected you over time. The study team will review your medical records to track your health outcomes. This is a registry-based study, meaning you're contributing your information to help researchers understand these conditions better rather than receiving a new treatment.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
United States
Enrollment target
~100 participants
Started
January 2024
Primary completion
January 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Julia Dai, MD
M.D. Anderson Cancer Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.